- By insider
CEO and Chairman of the Board of Athenex Inc (ATNX) Johnson Yiu Nam Lau bought 40,000 shares of ATNX on 11/14/2018 at an average price of $10.47 a share. The total cost of this purchase was $418,800.
Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Athenex Inc has a market cap of $680.010 million; its shares were traded at around $10.25 with and P/S ratio of 7.90.
-
Warning! GuruFocus has detected 2 Warning Signs with ATNX. Click here to check it out.
-
The intrinsic value of ATNX
CEO Recent Trades:
-
CEO and Chairman of the Board, 10% Owner Johnson Yiu Nam Lau bought 40,000 shares of ATNX stock on 11/14/2018 at the average price of $10.47. The price of the stock has decreased by 2.1% since.
CFO Recent Trades:
-
CFO Randoll Sze bought 1,000 shares of ATNX stock on 11/14/2018 at the average price of $10.26. The price of the stock has decreased by 0.1% since.
Directors and Officers Recent Trades:
-
See Remarks Jeffrey Yordon bought 9,500 shares of ATNX stock on 11/14/2018 at the average price of $10.49. The price of the stock has decreased by 2.29% since.
-
EVP, Chief Medical Officer Rudolf Kwan bought 10,000 shares of ATNX stock on 11/14/2018 at the average price of $10.49. The price of the stock has decreased by 2.29% since.
-
Director Jinn Wu bought 10,000 shares of ATNX stock on 11/14/2018 at the average price of $10.25. The price of the stock has decreased by 0% since.
-
See Remarks Simon Pedder bought 2,908 shares of ATNX stock on 11/14/2018 at the average price of $10.26. The price of the stock has decreased by 0.1% since.
For the complete insider trading history of ATNX, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 2 Warning Signs with ATNX. Click here to check it out.
-
The intrinsic value of ATNX